Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?
Epidemiological data strongly support the inverse association between high-density lipoprotein cholesterol concentration and cardiovascular risk. Over the last three decades, pharmaceutical strategies have been partially successful in raising high-density lipoprotein cholesterol concentration, but c...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-08-01
|
| Series: | JRSM Cardiovascular Disease |
| Online Access: | https://doi.org/10.1177/2048004019869736 |